Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients.
Cecile M YelnikClaire MartinEmmanuel LedoultSébastien SangesVincent SobanskiMeryem FarhatSandrine Morell-DuboisHélène MaillardElodie DrumezDavid LaunayEric HachullaMarc LambertPublished in: Lupus (2022)
Our finding suggested that dyslipidemia is frequent in APS patients and mainly insufficiently treated, especially in patients with history of CVD, who are at highest risk of future CV events.